Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NDRA market cap is 3.17M. The company's latest EPS is USD -19.4104 and P/E is -0.32.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.99M | -3.06M | -1.46M | -2.78M | -2.23M |
| Net Income | -2.56M | -3.1M | -1.46M | -2.78M | -2.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.84M | -11.5M | -11.5M | -13.16M | -10.52M |
| Net Income | -17.53M | -12.12M | -11.35M | -13.18M | -10.06M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.24M | 7.6M | 6.75M | 5.06M | 10.44M |
| Total Liabilities | 2.31M | 2.41M | 1.1M | 1.36M | 1.45M |
| Total Equity | 6.93M | 5.2M | 5.66M | 3.7M | 8.99M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.18M | 8.77M | 12.88M | 9.27M | 6.75M |
| Total Liabilities | 2.42M | 1.6M | 2.09M | 2.07M | 1.1M |
| Total Equity | 4.76M | 7.17M | 10.78M | 7.2M | 5.66M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.78M | -7.38M | -9.55M | -2.14M | -4.23M |
| Investing | -27k | -27k | -25k | -24k | -13k |
| Financing | 4.73M | 5.85M | 7.52M | 469k | 7.81M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.59M | -10.75M | -11.12M | -12.77M | -9.55M |
| Investing | -44k | -75k | -45k | -203k | -25k |
| Financing | 8.34M | 11.88M | 13.4M | 8.4M | 7.52M |
| Market Cap | 3.17M |
| Price to Earnings Ratio | -0.32 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.13 |
| Price to Book Ratio | 0.57 |
| Dividend Yield | - |
| Shares Outstanding | 518.28k |
| Average Volume (1 week) | 170.87k |
| Average Volume (1 Month) | 884.88k |
| 52 Week Change | -87.25% |
| 52 Week High | 138.50 |
| 52 Week Low | 0.1814 |
| Spread (Intraday) | 0.29 (4.68%) |
| Company Name | ENDRA Life Sciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.endrainc.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
